FY2018 Earnings Forecast for Steris PLC Issued By KeyCorp (STE)

Steris PLC (NYSE:STE) – Stock analysts at KeyCorp raised their FY2018 EPS estimates for shares of Steris in a report issued on Thursday. KeyCorp analyst M. Mishan now anticipates that the medical equipment provider will post earnings per share of $4.13 for the year, up from their previous estimate of $4.05. KeyCorp has a “Buy” rating and a $103.00 price objective on the stock. KeyCorp also issued estimates for Steris’ Q4 2018 earnings at $1.22 EPS, FY2019 earnings at $4.69 EPS and FY2020 earnings at $5.17 EPS.

Steris (NYSE:STE) last issued its earnings results on Wednesday, February 7th. The medical equipment provider reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.07 by $0.05. The company had revenue of $661.90 million for the quarter, compared to the consensus estimate of $663.17 million. Steris had a return on equity of 11.57% and a net margin of 9.42%. The firm’s quarterly revenue was up 2.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.98 EPS.

A number of other equities analysts also recently weighed in on STE. Raymond James Financial upped their target price on Steris from $95.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, October 16th. Zacks Investment Research downgraded Steris from a “buy” rating to a “sell” rating in a report on Monday, November 6th. TD Securities upped their target price on Steris from C$14.00 to C$16.00 and gave the company a “buy” rating in a report on Thursday, November 9th. Finally, Northcoast Research set a $102.00 target price on Steris and gave the company a “buy” rating in a report on Thursday. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $84.80.

Steris (STE) opened at $85.57 on Monday. The firm has a market capitalization of $7,290.00, a PE ratio of 30.13 and a beta of 1.22. Steris has a twelve month low of $66.84 and a twelve month high of $93.71. The company has a quick ratio of 2.18, a current ratio of 2.82 and a debt-to-equity ratio of 0.46.

A number of large investors have recently added to or reduced their stakes in the stock. Benjamin F. Edwards & Company Inc. increased its holdings in Steris by 5.9% in the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 9,817 shares of the medical equipment provider’s stock worth $859,000 after buying an additional 547 shares during the last quarter. Comerica Bank increased its holdings in Steris by 0.9% in the fourth quarter. Comerica Bank now owns 68,219 shares of the medical equipment provider’s stock worth $6,255,000 after buying an additional 628 shares during the last quarter. Crossmark Global Holdings Inc. increased its holdings in Steris by 6.9% in the fourth quarter. Crossmark Global Holdings Inc. now owns 9,810 shares of the medical equipment provider’s stock worth $858,000 after buying an additional 630 shares during the last quarter. Swiss National Bank increased its holdings in Steris by 0.6% in the third quarter. Swiss National Bank now owns 142,255 shares of the medical equipment provider’s stock worth $12,575,000 after buying an additional 800 shares during the last quarter. Finally, Barings LLC increased its holdings in Steris by 19.5% in the third quarter. Barings LLC now owns 4,900 shares of the medical equipment provider’s stock worth $433,000 after buying an additional 800 shares during the last quarter. Hedge funds and other institutional investors own 89.63% of the company’s stock.

In related news, VP Sudhir K. Pahwa sold 2,000 shares of the stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $92.09, for a total value of $184,180.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, VP John Adam Zangerle sold 3,650 shares of the stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $88.00, for a total value of $321,200.00. The disclosure for this sale can be found here. 2.55% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: “FY2018 Earnings Forecast for Steris PLC Issued By KeyCorp (STE)” was first posted by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international trademark & copyright law. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2018/02/12/fy2018-earnings-forecast-for-steris-plc-issued-by-keycorp-ste.html.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Earnings History and Estimates for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply